22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › TREACE MEDICAL CONCEPTS INC. › 2024-2025

TREACE MEDICAL CONCEPTS INC. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and TREACE MEDICAL CONCEPTS INC.’s Form 8-K, filed May 21, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 4Ballot items
  • 159Asset managers, any item
  • 664Fund votes
  • May 20, 2025Meeting date

Results at a glance

Meeting of May 20, 2025: 4 items on TREACE MEDICAL CONCEPTS INC.’s Form 8-K, filed May 21, 2025: 2 elected · 2 approved.

Dissent

Notable dissent: 1 director (17.7% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TREACE MEDICAL CONCEPTS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by TREACE MEDICAL CONCEPTS INC.

These tallies are TREACE MEDICAL CONCEPTS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 21, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TREACE MEDICAL CONCEPTS INC. — official shareholder meeting results, meeting held May 20, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Lawrence W. Hamilton 40,663,919---- 1,589,9839,208,628 96%Elected—
Elect Director: Deepti Jain 34,754,249---- 7,499,6539,208,628 82%Elected—
2. Advisory Vote on Executive Compensation 39,922,5802,315,84815,474 --9,208,628 95%Approved—
3. Ratification of Selection of Independent Registered Public Accounting Firm 51,392,62343,12726,780 --0 99.9%Approved—

Source: TREACE MEDICAL CONCEPTS INC., Form 8-K, filed with the SEC on May 21, 2025 — read the filing on EDGAR.

How asset managers voted at the TREACE MEDICAL CONCEPTS INC. 2024-2025 meeting

159 asset managers disclosed a vote on at least one TREACE MEDICAL CONCEPTS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Deepti Jain

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD
FOR: 34,754,249WITHHELD: 7,499,653
Details: description as filed, official tally, votes by 49 asset managers

Description as filed by funds: Election of Directors: Deepti Jain

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Elect Director: Deepti Jain”): 34,754,249 for, 7,499,653 withheld, per its Form 8-K filed May 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected, by the votes indicated below, the following nominees to the Company's Board of Directors to serve as Class I directors for a three-year term of office expiring at the 2028 annual meeting of stockholders or until their respective successors have been duly elected and qualif…”
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 7,809,208 for, 1,960,645 withheld, 22,895 abstained.

FORWITHHOLD
FOR: 7,809,208ABSTAIN: 22,895WITHHOLD: 1,960,645
Largest asset managers voting on “Election of Directors: Deepti Jain” at TREACE MEDICAL CONCEPTS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,644,1070 00For
BlackRock2,066,8330 00For
WILLIAM BLAIR FUNDS00 01,028,480Withhold
Fidelity1,026,7470 00For
JPMorgan603,1600 00For
FIRST EAGLE FUNDS00 0378,491Withhold
BUFFALO FUNDS365,3930 00For
Charles Schwab349,4270 00For
TIAA245,0910 00For
Lincoln Financial161,0730 031,453Mixed
Equitable76,7650 058,150Mixed
Voya00 0120,107Withhold
AIG/SunAmerica00 063,537Withhold
Capitol Series Trust00 049,980Withhold
Grandeur Peak Global Trust45,6300 00For
SEI39,4720 00For
DRIEHAUS MUTUAL FUNDS00 039,076Withhold
NORTHERN LIGHTS FUND TRUST III36,6510 00For
Northern Trust00 036,257Withhold
Goldman Sachs00 033,516Withhold
Global X29,2170 00For
Nationwide14,1450 08,719Mixed
RBB FUND, INC.00 020,791Withhold
Harbor ETF Trust19,0960 00For
State Street19,0760 00For

Showing the 25 largest of 49 asset managers. All 49 are in the interactive database (link above).

Elect Director: Lawrence W. Hamilton

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 40,663,919WITHHELD: 1,589,983
Details: description as filed, official tally, votes by 49 asset managers

Description as filed by funds: Election of Directors: Lawrence W. Hamilton

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Elect Director: Lawrence W. Hamilton”): 40,663,919 for, 1,589,983 withheld, per its Form 8-K filed May 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected, by the votes indicated below, the following nominees to the Company's Board of Directors to serve as Class I directors for a three-year term of office expiring at the 2028 annual meeting of stockholders or until their respective successors have been duly elected and qualif…”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 9,732,250 for, 54,295 withheld, 6,203 abstained.

FOR
FOR: 9,732,250ABSTAIN: 6,203WITHHOLD: 54,295
Largest asset managers voting on “Election of Directors: Lawrence W. Hamilton” at TREACE MEDICAL CONCEPTS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,644,1070 00For
BlackRock2,066,8330 00For
WILLIAM BLAIR FUNDS1,028,4800 00For
Fidelity1,026,7470 00For
JPMorgan603,1600 00For
FIRST EAGLE FUNDS378,4910 00For
BUFFALO FUNDS365,3930 00For
Charles Schwab349,4270 00For
TIAA245,0910 00For
Lincoln Financial192,5260 00For
Equitable134,9150 00For
Voya120,1070 00For
AIG/SunAmerica63,5370 00For
Capitol Series Trust49,9800 00For
Grandeur Peak Global Trust45,6300 00For
SEI39,4720 00For
DRIEHAUS MUTUAL FUNDS39,0760 00For
NORTHERN LIGHTS FUND TRUST III00 036,651Withhold
Northern Trust36,2570 00For
Goldman Sachs33,5160 00For
Global X29,2170 00For
Nationwide22,8640 00For
RBB FUND, INC.20,7910 00For
Harbor ETF Trust19,0960 00For
State Street19,0760 00For

Showing the 25 largest of 49 asset managers. All 49 are in the interactive database (link above).

Advisory Vote on Executive Compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 39,922,580AGAINST: 2,315,848

Prior year: 91.8% for (May 21, 2024 meeting) ▲ 2.7 pts

Details: description as filed, official tally, votes by 157 asset managers

Description as filed by funds: Approval, on an advisory, non- binding basis, of the compensation of the Company's named executive officers.

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“2. Advisory Vote on Executive Compensation”): 39,922,580 for, 2,315,848 against — passed, per its Form 8-K filed May 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “By the vote stated below, the stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of TREACE MEDICAL CONCEPTS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Approval, on an advisory, non-binding basis, of the H of the Company's named executive officers.” (2 managers, 49,980 for, 36,651 against).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 48 asset managers voting on “Approval, on an advisory, non- binding basis, of the compensation of the Company's named executive officers.” at TREACE MEDICAL CONCEPTS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,644,1070 00For
BlackRock2,066,8330 00For
WILLIAM BLAIR FUNDS1,028,4800 00For
Fidelity1,026,7470 00For
JPMorgan603,1600 00For
FIRST EAGLE FUNDS378,4910 00For
BUFFALO FUNDS365,3930 00For
Charles Schwab349,4270 00For
TIAA245,0910 00For
Lincoln Financial192,5260 00For
Equitable134,9150 00For
Voya120,1070 00For
Gabelli92,5000 00For
AIG/SunAmerica63,5370 00For
Grandeur Peak Global Trust45,6300 00For
SEI039,472 00Against
DRIEHAUS MUTUAL FUNDS39,0760 00For
Northern Trust36,2570 00For
Goldman Sachs33,5160 00For
Global X029,217 00Against
Nationwide21,2701,594 00Mixed
RBB FUND, INC.20,7910 00For
Harbor ETF Trust019,096 00Against
State Street19,0760 00For
FORUM FUNDS18,8950 00For

Fund voting reports, all 48 managers: 9,684,305 for, 104,981 against, 9,331 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 122 asset managers voting on “Approval, on an advisory, non- binding basis, of the compensation of the Company's named executive officers.” at TREACE MEDICAL CONCEPTS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
CIBC Private Wealth Group LLC15,187,4640 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC2,466,6550 00For
BlackRock1,545,21055,770 00For
JPMorgan1,392,1530 00For
GEODE CAPITAL MANAGEMENT, LLC1,081,3910 00For
State Street901,5614,738 00For
First Eagle Investment Management, LLC436,7870 00For
Northern Trust415,3502,316 00For
DRIEHAUS CAPITAL MANAGEMENT LLC369,9470 00For
Charles Schwab349,4290 00For
Nuveen246,6000 00For
DE Shaw208,2590 00For
STIFEL NICOLAUS & CO INC \MO\186,5750 00For
Citadel185,7860 00For
Birchview Capital, LP164,3500 00For
MELLON INVESTMENTS Corp159,1610 00For
UBS154,9250 00For
Two Sigma135,5640 00For
Voya120,1070 00For
Vanguard95,2580 00For
Connor, Clark & Lunn Investment Management Ltd.83,6540 00For
Lisanti Capital Growth, LLC81,2250 00For
FULLER & THALER ASSET MANAGEMENT, INC.73,9000 00For
Accredited Investors Inc.69,0000 00For
Fidelity67,2240 00For

Institutional-manager reports, all 122 managers: 26,590,946 for, 388,354 against, 165 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of Selection of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 51,392,623AGAINST: 43,127

Prior year: 96.2% for (May 21, 2024 meeting) ▲ 3.7 pts

Details: description as filed, official tally, votes by 50 asset managers

Description as filed by funds: Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“3. Ratification of Selection of Independent Registered Public Accounting Firm”): 51,392,623 for, 43,127 against — passed, per its Form 8-K filed May 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “By the vote stated below, the stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 50 asset managers below reported 9,875,917 for, 9,331 abstained.

FOR
FOR: 9,875,917ABSTAIN: 9,331
Largest asset managers voting on “Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accountin” at TREACE MEDICAL CONCEPTS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,644,1070 00For
BlackRock2,066,8330 00For
WILLIAM BLAIR FUNDS1,028,4800 00For
Fidelity1,026,7470 00For
JPMorgan603,1600 00For
FIRST EAGLE FUNDS378,4910 00For
BUFFALO FUNDS365,3930 00For
Charles Schwab349,4270 00For
TIAA245,0910 00For
Lincoln Financial192,5260 00For
Equitable134,9150 00For
Voya120,1070 00For
Gabelli92,5000 00For
AIG/SunAmerica63,5370 00For
Capitol Series Trust49,9800 00For
Grandeur Peak Global Trust45,6300 00For
SEI39,4720 00For
DRIEHAUS MUTUAL FUNDS39,0760 00For
NORTHERN LIGHTS FUND TRUST III36,6510 00For
Northern Trust36,2570 00For
Goldman Sachs33,5160 00For
Global X29,2170 00For
Nationwide22,8640 00For
RBB FUND, INC.20,7910 00For
Harbor ETF Trust19,0960 00For

Showing the 25 largest of 50 asset managers. All 50 are in the interactive database (link above).

Largest TREACE MEDICAL CONCEPTS INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 62,904,952 shares outstanding at the time of that meeting.

Fund voting reports: top TREACE MEDICAL CONCEPTS INC. shareholders by shares voted on “Ratification of the appointment of Grant Thornton LLP as the Company's independent registered…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 4.20%
2BlackRock 3.29%
3WILLIAM BLAIR FUNDS 1.63%
4Fidelity 1.63%
5JPMorgan 0.96%
6FIRST EAGLE FUNDS 0.60%
7BUFFALO FUNDS 0.58%
8Charles Schwab 0.56%
9TIAA 0.39%
10Lincoln Financial 0.31%
Institutional-manager reports: top TREACE MEDICAL CONCEPTS INC. shareholders by shares voted on “Approval, on an advisory, non- binding basis, of the compensation of the Company's named…”, 2024-2025
#Asset manager % of shares outstanding
1CIBC Private Wealth Group LLC 24.14%
2WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 3.92%
3BlackRock 2.55%
4JPMorgan 2.21%
5GEODE CAPITAL MANAGEMENT, LLC 1.72%
6State Street 1.44%
7First Eagle Investment Management, LLC 0.69%
8Northern Trust 0.66%
9DRIEHAUS CAPITAL MANAGEMENT LLC 0.59%
10Charles Schwab 0.56%

Reported TREACE MEDICAL CONCEPTS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

TREACE MEDICAL CONCEPTS INC. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Neil Gagnon6,142,107 9.76%Schedule 13G, filed February 12, 2026
BlackRock3,883,500 6.17%Form 13F, quarter ended March 31, 2025
BANK OF AMERICA CORP /DE/3,533,774 5.62%Schedule 13G, filed May 14, 2026
Vanguard Group2,705,023 4.30%Form 13F, quarter ended March 31, 2025
JPMorgan Chase1,848,997 2.94%Form 13F, quarter ended March 31, 2025
Morgan Stanley1,532,143 2.44%Form 13F, quarter ended March 31, 2025
Geode Capital1,087,143 1.73%Form 13F, quarter ended March 31, 2025
State Street982,783 1.56%Form 13F, quarter ended March 31, 2025
D.E. Shaw920,174 1.46%Form 13F, quarter ended March 31, 2025
Northern Trust491,183 0.78%Form 13F, quarter ended March 31, 2025

Percentages above are of 62,904,952 shares outstanding, as reported by TREACE MEDICAL CONCEPTS INC. on its Form 10-Q dated April 30, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At TREACE MEDICAL CONCEPTS INC.'s shareholder meeting held May 20, 2025, in the 2024-2025 proxy season, 159 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 664 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory, non- binding basis, of the compensation of the Company's named… — TREACE MEDICAL CONCEPTS INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: TREACE MEDICAL CONCEPTS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 21, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TREACE MEDICAL CONCEPTS INC.’s 10-Q dated April 30, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

TREACE MEDICAL CONCEPTS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “TREACE MEDICAL CONCEPTS (TMCI) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/treace-medical-concepts-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.